Demaret, Tanguy ; Université de Liège - ULiège > Faculté de Médecine > Mast. spéc. gén. clin.
Sokal, Etienne; UCL Saint-Luc - Cliniques Universitaires Saint-Luc [BE] > Département de pédiatrie > Service de gastro-entérologie et hépatologie pédiatrique
Gurevich M, et al. Living donor liver transplantation in children: surgical and immunological results in 250 recipients at Universite Catholique de Louvain. Ann Surg. 2015;262(6):1141-1149.
Otte JB, et al. Pediatric liver transplantation: from the full-size liver graft to reduced, split, and living related liver transplantation. Pediatr Surg Int. 1998;13(5-6):308-318.
Smets F, Najimi K, Sokal EM. Cell transplantation in the treatment of liver diseases. Pediatr Transplant. 2008;12(1):6-13.
Fox IJ, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 1998;338(20):1422-1426.
Lombard CA, Prigent J, Sokal EM, Human liver progenitor cells for liver repair. Cell Med. 2013;5(1):1-16.
Habibullah CM, et al. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation. 1994;58(8):951-952.
Grossman M, et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med. 1995;1(11):1148-1154.
Khan AA, et al. Management of hyperbilirubinemia in biliary atresia by hepatic progenitor cell transplantation through hepatic artery: a case report. Transplant Proc. 2008;40(4):1153-1155.
Stephenne X, et al. Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant. 2005;5(8):2058-2061.
Khan AA, et al. Treatment of Crigler-Najjar Syndrome type 1 by hepatic progenitor cell transplantation: a simple procedure for management of hyperbilirubinemia. Transplant Proc. 2008;40(4):1148-1150.
Gramignoli R, et al. Clinical hepatocyte transplantation: practical limits and possible solutions. Eur Surg Res. 2015;54(3-4):162-177.
Hughes RD, et al. Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl. 2006;12(5):713-717.
Mitry RR, et al. One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation. 2004;77(10):1614-1616.
Stephenne X, et al. Hepatocyte transplantation using the domino concept in a child with tetrabiopterin nonresponsive phenylketonuria. Cell Transplant. 2012;21(12):2765-2770.
Gramignoli R, et al. New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants. Stem Cell Res. 2013;11(1):563-573.
Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol. 1976;13:29-83.
Strom SC, et al. Isolation, culture, transplantation of human hepatocytes. J Natl Cancer Inst. 1982;68(5):771-778.
Pareja E, Gomez-Lechon ML, Tolosa L. Alternative cell sources to adult hepatocytes for hepatic cell therapy. Methods Mol Biol. 2017;1506:17-42.
Stephenne X, et al. Cryopreservation of human hepatocytes alters the mitochondrial respiratory chain complex 1. Cell Transplant. 2007;16(4):409-419.
Mitry RR, et al. Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant. 2003;12(1):69-74.
Gramignoli R, et al. Rapid and sensitive assessment of human hepatocyte functions. Cell Transplant. 2014;23(12):1545-1556.
Sussman NL, Kelly JH. Artificial liver: a forthcoming attraction. Hepatology. 1993;17(6):1163-1164.
Stephenne X, et al. Tissue factor-dependent procoagulant activity of isolated human hepatocytes: relevance to liver cell transplantation. Liver Transpl. 2007;13(4):599-606.
Ribes-Koninckx C, et al. Clinical outcome of hepatocyte transplantation in four pediatric patients with inherited metabolic diseases. Cell Transplant. 2012;21(10):2267-2282.
Strom SC, et al. Transplantation of human hepatocytes. Transplant Proc. 1997;29(4):2103-2106.
Meyburg J, et al. Monitoring of intraportal liver cell application in children. Cell Transplant. 2010;19(5):629-638.
Bohnen NI, et al. Use of indium-111-labeled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion. Clin Nucl Med. 2000;25(6):447-450.
Stephenne X, et al. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology. 2006;130(4):1317-1323.
Beck BB, et al. Liver cell transplantation in severe infantile oxalosis—a potential bridging procedure to orthotopic liver transplantation? Nephrol Dial Transplant. 2012;27(7):2984-2989.
Strom SC, et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation. 1997;63(4):559-569.
Wang LJ, et al. Engraftment assessment in human and mouse liver tissue after sex-mismatched liver cell transplantation by real-time quantitative PCR for Y chromosome sequences. Liver Transpl. 2002;8(9):822-828.
Soltys KA, et al. Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol. 2017;66(5):987-1000.
Sempoux C, et al. Severe radiation-induced liver disease following localized radiation therapy for biliopancreatic carcinoma: activation of hepatic stellate cells as an early event. Hepatology. 1997;26(1):128-134.
Sokal EM, et al. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, metabolic follow-up. Transplantation. 2003;76(4):735-738.
Jorns C, et al. De novo donor-specific HLA antibody formation in two patients with Crigler-Najjar syndrome type I following human hepatocyte transplantation with partial hepatectomy preconditioning. Am J Transplant. 2016;16(3):1021-1030.
Caplan AI, Mesenchymal stem cells: time to change the name! Stem Cells Transl Med. 2017;6(6):1445-1451.
Iansante V, Chandrashekran A, Dhawan A. Cell-based liver therapies: past, present and future. Philos Trans R Soc Lond B Biol Sci. 2018;373(1750):.
Evans MJ, Kaufman MH, Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292(5819):154-156.
Thomson JA, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145-1147.
Ghaedi M, et al. Hepatic differentiation of human embryonic stem cells on growth factor-containing surfaces. J Tissue Eng Regen Med. 2014;8(11):886-895.
Takayama K, et al. Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4alpha transduction. Mol Ther. 2012;20(1):127-137.
Hannan NR, et al. Production of hepatocyte-like cells from human pluripotent stem cells. Nat Protoc. 2013;8(2):430-7.
Chiang CH, et al. Induced pluripotent stem cells and hepatic differentiation. J Chin Med Asso. 2013;76(11):599-605.
Mora C, et al. Clinical potentials of human pluripotent stem cells. Cell Biol Toxicol. 2017;33(4):351-360.
Friedenstein AJ, Piatetzky S, II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966;16(3):381-390.
Pittenger MF, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147.
Alfaifi M, et al. Mesenchymal stromal cell therapy for liver diseases. J Hepatol. 2018;68(6):1272-1285.
Sokal EM, Lombard C, Mazza G., Mesenchymal stem cell treatment for hemophilia: a review of current knowledge. J Thromb Haemost. 2015;13(Suppl 1):S161-S166.
Fitzsimmons REB, et al. Mesenchymal stromal/stem cells in regenerative medicine and tissue engineering. Stem Cells Int. 2018;2018:8031718.
Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.
Klyushnenkova E, et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, suppression. J Biomed Sci. 2005;12(1):47-57.
Turner R, et al. Human hepatic stem cell and maturational liver lineage biology. Hepatology. 2011;53(3):1035-1045.
Najimi M, et al. Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant. 2007;16(7):717-728.
Dollet PE, et al. Comprehensive screening of cell surface markers expressed by adult-derived human liver stem/progenitor cells harvested at passage 5: potential implications for engraftment. Stem Cells Int. 2016;2016:9302537.
Sana G, et al. Adult human hepatocytes promote CD4(+): T-cell hyporesponsiveness via interleukin-10-producing allogeneic dendritic cells. Cell Transplant. 2014;23(9):1127-1142.
Sokal EM, et al. Biodistribution of liver-derived mesenchymal stem cells after peripheral injection in a hemophilia A patient. Transplantation. 2017;101(8):1845-1851.
Khuu DN, et al. in vitro differentiated adult human liver progenitor cells display mature hepatic metabolic functions: a potential tool for in vitro pharmacotoxicological testing. Cell Transplant. 2011;20(2):287-302.
Sokal EM. Treating inborn errors of liver metabolism with stem cells: current clinical development. J Inherit Metab Dis. 2014;37(4):535-539.
Herrera M., et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells. 2006;24(12):2840-2850.
Sokal EM, et al. Liver engraftment and repopulation by in vitro expanded adult-derived human liver stem cells in a child with ornithine carbamoyltransferase deficiency. JIMD Rep. 2014;1365-1372.
Najimi M, Defresne F, Sokal EM. Concise review: updated advances and current challenges in cell therapy for inborn liver metabolic defects. Stem Cells Transl Med. 2016;5(8):1117-1125.
Defresne F, et al. Biodistribution of adult derived human liver stem cells following intraportal infusion in a 17-year-old patient with glycogenosis type 1A. Nucl Med Biol. 2014;41(4):371-375.
Smets F, et al. Phase I/II prospective, open label, multicenter, partially randomized, safety study of one cycle of promethera HepaStem in urea cycle defects and Crigler-Najjar syndrome. Presented at the 47th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. Jerusalem, Israel; 2014:121-122.
Scheers I, et al. Adult-derived human liver progenitor cells in long-term culture maintain appropriate gatekeeper mechanisms against transformation. Cell Transplant. 2012;21(10):2241-2255.
Scheers I, et al. Human umbilical cord matrix stem cells maintain multilineage differentiation abilities and do not transform during long-term culture. PLoS One. 2013;8(8):e71374.
Meier RP, et al. Transplantation of mesenchymal stem cells for the treatment of liver diseases. Is there enough evidence? Stem Cell Res. 2013;11(3):1348-1364.
Yamanaka S, Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B Biol Sci. 2008;363(1500):2079-2087.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676.
Park IH, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451(7175):141-146.
Pashos EE, et al. Large, diverse population cohorts of hiPSCs and derived hepatocyte-like cells reveal functional genetic variation at blood lipid-associated loci. Cell Stem Cell. 2017;20(4):558-570. e10.
Wang Y, et al. Defined and scalable generation of hepatocyte-like cells from human pluripotent stem cells. J Vis Exp 2017;March 2:(121):.
Singer NG, Caplan AJ. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol. 2011;6457-6478.
Luz-Crawford P, et al. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther. 2013;4(3):65.
Mantovani A, et al. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2013;229(2):176-185.
Owen A, Newsome PN. Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt? Am J Physiol Gastrointest Liver Physiol. 2015;309(10):G791-G800.
Berardis S, et al. Gene expression profiling and secretome analysis differentiate adult-derived human liver stem/progenitor cells and human hepatic stellate cells. PLoS One. 2014;9(1):e86137.
Melief SM, et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells. 2013;31(9):1980-1991.
Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9(1):11-15.
Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013;13(4):392-402.
Ren G, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2(2):141-150.
Kholodenko IV, et al. Cell therapy as a tool for induction of immunological tolerance after liver transplantation. Bull Exp Biol Med. 2018;165(4):554-563.
Shi M, et al. A pilot study of mesenchymal stem cell therapy for acute liver allograft rejection. Stem Cells Transl Med. 2017;6(12):2053-2061.
Najimi M, et al. Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation. Stem Cell Res Ther. 2017;8(1):131.
Gazdic M, et al. Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury. Liver Transpl. 2018;24(5):687-702.
Cao H, et al. Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure. BMC Med. 2012;10:56.
Zhao X, et al. Combined treatment with MSC transplantation and neutrophil depletion ameliorates D-GalN/LPS-induced acute liver failure in rats. Clin Res Hepatol Gastroenterol. 2016;40(6):730-738.
Fu X, et al. Heterogenic transplantation of bone marrow-derived rhesus macaque mesenchymal stem cells ameliorates liver fibrosis induced by carbon tetrachloride in mouse. PeerJ. 2018;6e:4336.
Winkler S, et al. Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model. Exp Cell Res. 2014;326(2):230-239.
Arsenijevic A, et al. Mesenchymal stem cells as new therapeutic agents for the treatment of primary biliary cholangitis. Anal Cell Pathol (Amst). 2017;2017:7492836.
Prasanna SJ, et al. Pro-inflammatory cytokines, IFN gamma and TNF alpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One. 2010;5(2):e9016.
Melief SM, et al. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med. 2013;2(6):455-463.
Chao YH, et al. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis. PLoS One. 2014;9(10):e110338.
Mazza G, et al. Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation. Sci Rep. 2015;5:13079.
Moroni L, et al. Biofabrication: a guide to technology and terminology. Trends Biotechnol. 2018;36(4):384-402.
Sawa Y, et al. Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case. Surg Today. 2012;42(2):181-184.
Soriano HE, et al. Hepatocyte transplantation (HCT): in children with fulminant liver failure (FLF):. Hepatology. 1997;26(239A):443.
Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis. 1999;19(1):39-48.
Puppi J, Dhawan A. Human hepatocyte transplantation overview. Methods Mol Biol. 2009;48:11-16.
Hansel MC, et al. The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients. Curr Protoc Toxicol. 2014;62:14.12.1-23.
Khan Z, Strom SC. Hepatocyte transplantation in special populations: clinical use in children. Methods Mol Biol. 2017;1506:3-16.
Darwish AA, et al. Permanent access to the portal system for cellular transplantation using an implantable port device. Liver Transpl. 2004;10(9):1213-1215.
Ambrosino G, et al. Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant. 2005;14(2-3):151-157.
Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis. 2006;29(2-3):431-435.
Allen KJ, et al. Cell-mediated rejection results in allograft loss after liver cell transplantation. Liver Transpl. 2008;14(5):688-694.
Lysy PA, et al. Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives. World J Gastroenterol. 2008;14(22):3464-3470.
Sanna C, et al. Homozygous familial hypercholesterolemia in childhood: Genotype-phenotype description, established therapies and perspectives. Atherosclerosis. 2016;247:97-104.
Dhawan A, et al. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation. 2004;78(12):1812-1814.
Lee KW, et al. Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant. 2007;16(6):629-637.
Horslen SP, et al. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics. 2003;111(6 Pt 1):1262-1267.
Darwish AA, et al. Permanent access to the portal system for cellular transplantation using an implantable port device. Liver Transpl. 2004;10(9):1213-1215.
Puppi J, et al. Hepatocyte transplantation followed by auxiliary liver transplantation—a novel treatment for ornithine transcarbamylase deficiency. Am J Transplant. 2008;8(2):452-457.
Meyburg J, et al. One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation. 2009. 87(5):636-641.
Enosawa S, et al. Hepatocyte transplantation using a living donor reduced graft in a baby with ornithine transcarbamylase deficiency: a novel source of hepatocytes. Liver Transpl. 2014;20(3):391-393.
